Results 191 to 200 of about 472,378 (232)

Correction: VZV IE4 downregulates cellular surface MHC-I via sequestering it to the golgi complex. [PDF]

Cell Mol Life Sci
Ye Y, Li S, Yan X, Zheng Q, Xue M, Wang H, Zheng C.   +6 more
europepmc   +1 more source

Architectural principles of transporter-chaperone coupling within the native MHC I peptide-loading complex. [PDF]

Sci Adv
Stolz M, Sušac L, Fahim A, Keller R, Saggau L, Mancia F, Trowitzsch S, Tampé R.   +7 more
europepmc   +1 more source

Dual role of IFNγ in reprogramming the undifferentiated pleomorphic sarcoma cell line JBT19 towards cytotoxic chemotherapy and antitumor immunity. [PDF]

Oncol Lett
Taborska P, Stakheev D, Smrz D.
europepmc   +1 more source

In silico design of a multi-epitope vaccine against the triple negative breast cancer. [PDF]

Sci Rep
Zahraei M, Roohparvar Basmenj E, Behrouzi G, Heidari Keshel S, Alem M.   +4 more
europepmc   +1 more source

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer. [PDF]

Nat Commun
Meder L, Orschel CI, Bouchez CL, Gholamipoorfard R, Orschel CV, Stahl D, Kreer C, Koker M, Nill M, Kocak IG, Noh KW, Zhao X, Ullrich L, Häupl B, Jakob J, Eich ML, Florin A, Grüll H, Wolf J, Beleggia F, Büttner R, Oellerich T, Klein F, Brägelmann J, Reinhardt HC, Abedpour N, Ullrich RT.   +26 more
europepmc   +1 more source

From MHC-mismatch to MHC-match

, 2004
Schulte, F, Zhang, EP, Schroff, M, Müller, A, Wittig, B, Ignatius, R, Hoffmann, F   +6 more
openaire   +1 more source

Neoantigens in cancer immunoediting: from mechanisms to personalized vaccines in breast cancer. [PDF]

Front Cell Dev Biol
Zeng S, Wang L, Zeng W, Sun L.
europepmc   +1 more source

MHC-class I restricted peptidebasedimmunomodulation of CD8+T and NK cells

, 2012
Adil Doganay Duru
openalex